Back

Safety of sodium-glucose cotransporter-2 inhibitor in low body mass index patients who have heart failure with reduced ejection fraction

9 May 2026 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - pharmacotherapy (8) Pharmacotherapy Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Jeen Hwa Lee

Dongtan Sacred Heart Hospital, Hwaseong (Korea (Republic of))

5 More presentations in this session

Presentation thumbnail
Evolution of heart failure management in korea: a serial comparison of physician awareness and practice patterns (2019 vs. 2025)
Associate Professor S. Lee (Seoul, KR)
Abstract
Presentation thumbnail
Variation in initial pharmacological therapy for heart failure with reduced ejection fraction: an international case-based survey
Mr H. Amin (Enschede, NL)
Abstract
Presentation thumbnail
Implementation of guideline-directed pharmacotherapy in hospitalized and outpatient heart failure care: a web-based survey
Professor M. Tokmakova (Plovdiv, BG)
Abstract
Presentation thumbnail
Patient and prescriber knowledge of SGLT2i sick day rules: a single centre cohort study
Doctor B. Woolfenden (Dublin 9, IE)
Abstract
Presentation thumbnail
Evaluating sglt2 inhibitor application in heart failure patients across the spectrum in a large multi-hospital healthcare network
Mrs X. Zalazar (Atlanta, US)
Abstract

Access the full session

Session thumbnail
ePosters in chronic heart failure - pharmacotherapy (8)

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026
You may be interested in
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios
thumbnail
Congress Presentation
Audience Q&A
thumbnail
Congress Presentation
Did we forget ARNI in the era of SGLTi?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources